Startseite Crystal structure of chlorido-(4-methyl-2-((phenylimino)methyl)phenolato-κ2 N,O)-(pyridine-κ1 N)platinum(II), C19H17ClN2OPt
Artikel Open Access

Crystal structure of chlorido-(4-methyl-2-((phenylimino)methyl)phenolato-κ2 N,O)-(pyridine-κ1 N)platinum(II), C19H17ClN2OPt

  • Arshad Khan ORCID logo EMAIL logo , Rabia Usman , Moamen S. Refat , Abeer M. Alosaimi , Mohammed T. Alghamdi und Faiz-Ur Rahman EMAIL logo
Veröffentlicht/Copyright: 8. September 2021

Abstract

C10H8BrN3, orthorhombic, P 1 (no. 2), a = 12.114(7) Å, b = 12.254(8) Å, c = 13.186(8) Å, α = 71.659(10)°, β = 84.744(10)°, γ = 89.725(10)°, V = 1850(2) Å3, Z = 4, R gt (F) = 0.0511, wR ref (F 2) = 0.1644, T = 293 K.

CCDC no.: 2106192

One of the two crystallographically independent tile complexes is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Yellow block
Size: 0.55 × 0.40 × 0.20 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 7.74 mm−1
Diffractometer, scan mode: Bruker APEX-II, φ and ω
θ max, completeness: 27.6°, 99%
N(hkl)measuredN(hkl)uniqueR int: 13,405, 8311, 0.042
Criterion for I obs, N(hkl)gt: I obs > 2 σ(I obs), 5880
N(param)refined: 435
Programs: Bruker [1], SHELX [2], Diamond [3]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z U iso*/U eq
Pt1 0.18009 (3) 0.03568 (3) 0.19872 (3) 0.03592 (13)
Pt2 0.68252 (3) 0.33125 (3) 0.19834 (3) 0.03727 (13)
Cl1 0.1784 (2) −0.1114 (3) 0.1260 (3) 0.0605 (8)
Cl2 0.6815 (2) 0.5276 (2) 0.1190 (3) 0.0655 (8)
N1 0.0221 (7) 0.0089 (7) 0.2603 (7) 0.0377 (17)
N2 0.3379 (7) 0.0727 (8) 0.1339 (7) 0.044 (2)
N3 0.5231 (7) 0.3216 (7) 0.2591 (7) 0.0383 (18)
N4 0.8425 (7) 0.3338 (7) 0.1330 (7) 0.044 (2)
O1 0.2002 (5) 0.1639 (7) 0.2583 (7) 0.055 (2)
O2 0.7023 (6) 0.1616 (6) 0.2605 (6) 0.0460 (17)
C1 0.1246 (8) 0.2057 (9) 0.3107 (8) 0.041 (2)
C2 0.0142 (8) 0.1610 (8) 0.3430 (8) 0.038 (2)
C3 −0.0624 (9) 0.2186 (9) 0.3918 (9) 0.047 (2)
H3 −0.1352 0.1901 0.4083 0.056*
C4 −0.0347 (9) 0.3181 (9) 0.4173 (9) 0.047 (2)
C5 0.0748 (10) 0.3574 (11) 0.3896 (10) 0.059 (3)
H5 0.0968 0.4210 0.4075 0.070*
C6 0.1511 (9) 0.3073 (10) 0.3377 (10) 0.051 (3)
H6 0.2224 0.3394 0.3189 0.061*
C7 −0.0295 (8) 0.0678 (8) 0.3133 (8) 0.039 (2)
H7 −0.1039 0.0481 0.3352 0.047*
C8 −0.0496 (8) −0.0800 (8) 0.2439 (10) 0.045 (2)
C9 −0.0956 (9) −0.0643 (11) 0.1505 (11) 0.055 (3)
H9 −0.0782 0.0042 0.0955 0.066*
C10 −0.1643 (11) −0.1397 (12) 0.1311 (13) 0.066 (4)
H10 −0.1923 −0.1263 0.0650 0.079*
C11 −0.1918 (13) −0.2434 (15) 0.2204 (17) 0.089 (6)
H11 −0.2404 −0.2981 0.2127 0.106*
C12 −0.1478 (14) −0.2616 (14) 0.3145 (18) 0.104 (6)
H12 −0.1648 −0.3295 0.3704 0.125*
C13 −0.0761 (11) −0.1785 (9) 0.3287 (10) 0.057 (3)
H13 −0.0472 −0.1899 0.3941 0.068*
C14 −0.1162 (12) 0.3737 (13) 0.4744 (16) 0.092 (6)
H14A −0.1250 0.3299 0.5492 0.137*
H14B −0.1862 0.3770 0.4449 0.137*
H14C −0.0903 0.4502 0.4660 0.137*
C15 0.3699 (9) 0.1831 (11) 0.0767 (9) 0.053 (3)
H15 0.3157 0.2385 0.0673 0.063*
C16 0.4750 (11) 0.2192 (11) 0.0318 (11) 0.062 (3)
H16 0.4933 0.2953 −0.0077 0.074*
C17 0.5541 (10) 0.1302 (17) 0.0509 (13) 0.083 (5)
H17 0.6273 0.1480 0.0221 0.099*
C18 0.5244 (9) 0.0173 (12) 0.1117 (10) 0.059 (3)
H18 0.5769 −0.0398 0.1255 0.071*
C19 0.4198 (9) −0.0059 (10) 0.1490 (8) 0.046 (2)
H19 0.4002 −0.0816 0.1886 0.056*
C20 0.6213 (8) 0.0837 (8) 0.3105 (7) 0.036 (2)
C21 0.5102 (7) 0.1110 (7) 0.3312 (7) 0.0316 (18)
C22 0.4337 (8) 0.0211 (10) 0.3808 (9) 0.050 (3)
H22 0.3612 0.0392 0.3978 0.059*
C23 0.4591 (9) −0.0885 (12) 0.4046 (10) 0.058 (3)
C24 0.5723 (9) −0.1174 (10) 0.3859 (9) 0.052 (3)
H24 0.5927 −0.1940 0.4060 0.062*
C25 0.6505 (9) −0.0315 (9) 0.3381 (9) 0.048 (3)
H25 0.7235 −0.0503 0.3240 0.057*
C26 0.4711 (8) 0.2236 (8) 0.3078 (8) 0.037 (2)
H26 0.3968 0.2290 0.3305 0.044*
C27 0.4550 (9) 0.4239 (10) 0.2484 (11) 0.053 (3)
C28 0.4387 (17) 0.4658 (13) 0.3326 (16) 0.100 (6)
H28 0.4726 0.4329 0.3952 0.120*
C29 0.3717 (18) 0.5569 (15) 0.3225 (18) 0.112 (6)
H29 0.3622 0.5886 0.3781 0.135*
C30 0.3179 (18) 0.6029 (16) 0.2331 (19) 0.112 (6)
H30 0.2704 0.6639 0.2282 0.134*
C31 0.3351 (14) 0.5581 (13) 0.1516 (15) 0.088 (5)
H31 0.3002 0.5900 0.0893 0.106*
C32 0.4021 (9) 0.4678 (11) 0.1590 (11) 0.061 (3)
H32 0.4116 0.4364 0.1032 0.073*
C33 0.3727 (10) −0.1838 (9) 0.4537 (11) 0.058 (3)
H33A 0.3303 −0.1695 0.5132 0.088*
H33B 0.4088 −0.2561 0.4782 0.088*
H33C 0.3242 −0.1863 0.4007 0.088*
C34 0.8717 (9) 0.2678 (11) 0.0737 (11) 0.060 (3)
H34 0.8171 0.2211 0.0620 0.072*
C35 0.9775 (10) 0.2635 (11) 0.0279 (12) 0.073 (4)
H35 0.9937 0.2153 −0.0132 0.088*
C36 1.0565 (11) 0.3303 (13) 0.0439 (12) 0.077 (4)
H36 1.1284 0.3290 0.0131 0.092*
C37 1.0331 (10) 0.4000 (12) 0.1046 (11) 0.066 (4)
H37 1.0877 0.4476 0.1147 0.079*
C38 0.9214 (9) 0.3987 (10) 0.1529 (10) 0.064 (4)
H38 0.9040 0.4427 0.1979 0.077*

Source of materials

The complex was synthesized in quantitate yield from our previously reported method [4]. Block-shaped yellow crystals of the title complex were grown by slow evaporation from their CH2Cl2 solution.

Experimental details

The hydrogen atoms were placed in calculated positions and refined using a riding mode. Some non-fitting reflections were removed manually. The structural model is not affected by this procedure.

Comment

Platinum metal-based complexes (cisplatin, carboplatin, and oxaliplatin) draw immense attention owing to their anticancer potentials. The interest in Pt-based complexes growing worldwide interest due to their ease of synthesis, stability, favorable therapeutic indices, lower toxicity, etc. [4]. The chemistry of platinum complexes has been extensively studied owing to their antitumor/anticancer properties [5], [6], [7], [8], [9], [10], [11], [12], [13] and as a sensor [14, 15].

The asymmetric unit of the title structure contains two Pt-complexes. Each Pt is coordinated by nitrogen and oxygen atom to form a six-member ring and exhibited a square planar environment because the angles of OPtCl and N1PtN2 were ca. 180° respectively. The crystal structures is assembled by collaborative π–π interactions (3.345 Å between pyridine and benzene ring) and CH⃛π bonds (3.110 Å) to form a linear chain along the c-axis.


Corresponding authors: Arshad Khan, School of Chemistry and Environmental Engineering, Sichuan University of Science & Engineering, Zigong 643000, Sichuan, P. R. China, E-mail: ; and Faiz-Ur Rahman, Inner Mongolia University Research Center for Glycochemistry of Characteristic Medicinal Resources, School of Chemistry and Chemical Engineering, Inner Mongolia University, Hohhot, 010021, P. R. China, E-mail:

Funding source: Sichuan University of Science & Engineering

Funding source: Taif University http://dx.doi.org/10.13039/501100006261

Award Identifier / Grant number: TURSP-2020/01

Funding source: Inner Mongolia University

Award Identifier / Grant number: No.10000-21311201/092

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This research was financially supported by the Scientific Research Foundation for Talents, Sichuan University of Science & Engineering, Taif University Researches Supporting Project number (TURSP-2020/01), Taif University, Taif, Saudi Arabia. Inner Mongolia University funding under the title Academic Backbone (No.10000-21311201/092).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. BRUKER. SAINT, APEX2 and SADABS; Bruker AXS Inc.: Madison, Wisconsin, USA, 2009.Suche in Google Scholar

2. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar

3. Brandenburg, K. DIAMOND. Visual Crystal Structure Information System (Ver. 4.0); Crystal Impact: Bonn, Germany, 2015.Suche in Google Scholar

4. Rahman, F.-U., Ali, A., Guo, R., Wang, W.-K., Wang, H., Li, Z.-T., Lin, Y., Zhang, D.-W. Efficient one-pot synthesis of trans- Pt(ii)(salicylaldimine)(4-picoline)Cl complexes: effective agents for enhanced expression of p53 tumor suppressor genes. Dalton Trans. 2015, 44, 9872–9880; https://doi.org/10.1039/c5dt01098e.Suche in Google Scholar PubMed

5. Rahman, F.-U., Ali, A., Guo, R., Zhang, Y.-C., Wang, H., Li, Z.-T., Zhang, D.-W. Synthesis and anticancer activities of a novel class of mono- and di- metallic Pt(ii)(salicylaldiminato)(DMSO or Picolino)Cl complexes. Dalton Trans. 2015, 44, 2166–2175; https://doi.org/10.1039/c4dt03018d.Suche in Google Scholar PubMed

6. Rahman, F.-U., Ali, A., Khan, I. U., Duong, H.-Q., Yu, S.-B., Lin, Y.-J., Wang, H., Li, Z.-T., Zhang, D.-W. Morpholine or methylpiperazine and salicylaldimine based heteroleptic square planner platinum (II) complexes: in vitro anticancer study and growth retardation effect on E. coli. Eur. J. Med. Chem. 2017, 131, 263–274; https://doi.org/10.1016/j.ejmech.2017.03.014.Suche in Google Scholar PubMed

7. Rahman, F.-U., Ali, A., Duong, H.-Q., Khan, I. U., Bhatti, M. Z., Li, Z.-T., Wang, H., Zhang, D.-W. ONS-donor ligand based Pt (II) complexes display extremely high anticancer potency through autophagic cell death pathway. Eur. J. Med. Chem. 2019, 164, 546–561; https://doi.org/10.1016/j.ejmech.2018.12.052.Suche in Google Scholar PubMed

8. Rahman, F.-U., Bhatti, M. Z., Ali, A., Duong, H.-Q., Zhang, Y., Yang, B., Koppireddi, S., Lin, Y., Wang, H., Li, Z.-T. Homo-and heteroleptic Pt (II) complexes of ONN donor hydrazone and 4-picoline: a synthetic, structural and detailed mechanistic anticancer investigation. Eur. J. Med. Chem. 2018, 143, 1039–1052; https://doi.org/10.1016/j.ejmech.2017.11.044.Suche in Google Scholar PubMed

9. Wilson, J. J., Lippard, S. J. Synthetic methods for the preparation of platinum anticancer complexes. Chem. Rev. 2014, 114, 4470–4495; https://doi.org/10.1021/cr4004314.Suche in Google Scholar PubMed PubMed Central

10. Bai, X., Ali, A., Lv, Z., Wang, N., Zhao, X., Hao, H., Zhang, Y., Rahman, F.-U. Platinum complexes inhibit HER-2 enriched and triple-negative breast cancer cells metabolism to suppress growth, stemness and migration by targeting PKM/LDHA and CCND1/BCL2/ATG3 signaling pathways. Eur. J. Med. Chem. 2021, 224, 113689; https://doi.org/10.1016/j.ejmech.2021.113689.Suche in Google Scholar PubMed

11. Rahman, F. U., Ali, A., Guo, R., Wang, W. K., Wang, H., Li, Z. T., Lin, Y., Zhang, D. W. Efficient one-pot synthesis of trans-Pt(II)(salicylaldimine)(4-picoline)Cl complexes: effective agents for enhanced expression of p53 tumor suppressor genes. Dalton Trans. 2015, 44, 9872–9880; https://doi.org/10.1039/c5dt01098e.Suche in Google Scholar

12. Rahman, F.-U., Ali, A., Khan, I., Guo, R., Chen, L., Wang, H., Li, Z.-T., Lin, Y., Zhang, D.-W. Synthesis and characterization of trans- Pt(II)(salicylaldimine)(pyridine/pyridine-4-carbinol)Cl complexes: in vivo inhibition of E. coli growth and in vitro anticancer activities. Polyhedron 2015, 100, 264–270; https://doi.org/10.1016/j.poly.2015.08.034.Suche in Google Scholar

13. Rahman, F.-U., Wang, H., Zhang, D.-W., Li, Z.-T. 42 members new hydroquinone bridged supramolecular macrocycle and its tetra-nuclear mixed ligands Pt(II) complex: a synthetic, structural and spectroscopic investigation. Inorg. Chem. Commun. 2018, 97, 157–165; https://doi.org/10.1016/j.inoche.2018.09.026.Suche in Google Scholar

14. Wong, Y.-S., Ng, M., Yeung, M. C.-L., Yam, V. W.-W. Platinum(II)-based host–guest coordination-driven supramolecular co-assembly assisted by Pt⃛Pt and pi–pi stacking interactions: a dual-selective luminescence sensor for cations and anions. J. Am. Chem. Soc. 2021, 143, 973–982; https://doi.org/10.1021/jacs.0c11162.Suche in Google Scholar PubMed

15. Kumar, P., Pachisia, S., Gupta, R. Turn-on detection of assorted phosphates by luminescent chemosensors. Inorg. Chem. Front. 2021, 8, 3587–3607; https://doi.org/10.1039/d1qi00032b.Suche in Google Scholar

Received: 2021-07-24
Accepted: 2021-08-29
Published Online: 2021-09-08
Published in Print: 2021-12-20

© 2021 Arshad Khan et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Redetermination of the crystal structure of 3-bromonitrobenzene at 200 K, C6H4BrNO2 – temperature effects on cell constants
  4. Crystal structure of (E)-ethyl 2-((4-oxo-4H-chromen-3-yl)methyleneaminooxy)acetate, C14H13NO5
  5. Crystal structure of (8R,10R,14R, Z)-2-((3–Fluoropyridin-4-yl) methylene)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((R)-2,6, 6-trimethyltetrahydro-2H-pyran-2-yl) hexadecahydro-3H-cyclopenta[a] phenanthren-3-one, C36H52FNO3
  6. Crystal structure of [6,6′-((1E,1′E)-(propane-1,3- diylbis(azaneylylidene))bis(methaneylylidene)) bis(3-chlorophenol)-κ4N,N′,O,O′] copper(II), C17H14Cl2CuN2O2
  7. The crystal structure of 6-amino-2-carboxypyridin-1-ium bromide, C6H7BrN2O2
  8. Redetermination of the crystal structure of bis[N,N′-ethylenebis(acetylacetoniminato)nickel(II)] sodium perchlorate, C24H36ClN4NaNi2O8
  9. The crystal structure of 3-methyl-2,6-dinitrophenol, C7H6N2O5
  10. The crystal structure of 5-chloro-2-(quinolin-8-yl)isoindoline-1,3-dione, C17H9ClN2O2
  11. Crystal structure of trans-tetraaqua-bis{2-carboxy-4-((5-carboxypyridin-3-yl)oxy)benzoato-κ1 N}cobalt(II) dihydrate C28H28O20N2Co
  12. Crystal structure of 3-allyl-4-(2-bromoethyl)-5-(4-methoxyphenyl)-2-(p-tolyl)furan, C23H23BrO2
  13. The crystal structure of 6,6′-(((2-(dimethylamino)ethyl)azanediyl)bis(methylene))bis(benzo[d][1,3]dioxol-5-ol ato-κ4N,N′,O,O′)-(pyridine-2,6-dicarboxylato-N,O,O′)-titanium(IV)-dichloromethane(1/1), C27H25N3O10Ti
  14. Crystal structure of (((1E,1′E)-1,2-phenylenebis(methaneylylidene))bis(hydrazin-1-yl-2-ylidene))bis(aminomethaniminium) dinitrate C10H16N10O6
  15. Crystal structure of catena-poly[triaqua-(μ 2-1,3-di(1H-imidazol-1-yl)propane-κ 2 N:N′)-(4,4′-(1H-1,2,4-triazole-3,5-diyl)dibenzoato-κ 1 O)nickel(II)]N,N′-dimethylformamide (1/1), C28H35N8O8Ni
  16. The crystal structure of 3,3′-[1,4-phenylenebis(methylene)]bis(1-ethenyl-1H-imidazol-3-ium) dichloride – dichloromethane – water (1/1/1), C19H24Cl4N4O1
  17. Crystal structure of 1,1′-(methane-1,1-diyl)bis(3-propyl-1H-imidazol-3-ium) bis(hexafluoridophosphate), C13H22F12N4P2
  18. Crystal structure of dichlorido-bis(4-chlorophenyl-κC 1)tin(IV), C12H8Cl4Sn
  19. Synthesis and crystal structure of 4-acetylpyrene, C18H12O
  20. Crystal structure of 2,2′-(butane-1,4-diylbis(azanylylidene))bis(methanylylidene))bis(4-methoxyphenol), C20H24N2O4
  21. The crystal structure of (E)-2-(((5-((triphenylstannyl)thio)-1,3,4-thiadiazol-2-yl)imino)methyl)phenol, C27H21N3OS2Sn
  22. Crystal structure of diaqua-bis(μ2-6-phenylpyridine-2-carboxylate-κ3N,O:O)-bis(6-phenylpyridine-2-carboxylato-κ2N,O)lead(II) – N,N-dimethylformamide – water (1/2/4), C54H58N6O16Pb2
  23. Crystal structure of methyl 4-acetoxy-3-methoxybenzoate, C11H12O5
  24. Crystal structure of 2,2′-(propane-1,3-dilylbis(azaneylylidene))bis(methanylylidene)bis(4-methylphenol), C19H22N2O2
  25. Crystal structure of dichlorido-bis(4-methylphenyl-κC1)tin(IV), C14H14Cl2Sn
  26. Crystal structure of methyl (E)-3-(4-acetoxyphenyl)acrylate, C12H12O4
  27. The crystal structure of bis(benzoato-κ2 O,O′)-(2,9-dimethyl-1,10-phenanthroline-κ2 N,N′)-copper(II), C28H22CuN2O4
  28. Crystal structure of (8R,10R,14R,Z)-12-hydroxy-2-((6-methoxypyridin-2-yl)methylene)-4,4,8,10,14-pentamethyl-17-((R)-2,6,6-trimethyltetrahydro-2H-pyran-2-yl)hexadecahydro-3H-cyclopenta[a]phenanthren-3-one–water (2/1), C37H56NO4.5
  29. Crystal structure of dimethyl-bis(4-bromophenyl-κC1)tin(IV), C14H14Br2Sn
  30. The crystal structure of the cocrystal di-μ2-chlorido-octamethyl-di-μ3-oxido-bis(2,3,4,5-tetrafluorobenzoato-κ2 O,O′)tetratin(IV) ─ octamethyl-di-μ3-oxido-bis(μ2-2,3,4,5-tetrafluorobenzoato-κ2 O:O′)-bis(μ2-2,3,4,5-tetrafluorobenzoato-κ2 O:O;O′)tetratin(IV) C58H54Cl2F24O16Sn8
  31. Crystal structure of 3-iodo-N 2-(2-methyl-1-(methylsulfonyl)propan-2-yl)-N 1-(2-methyl-4-(perfluoropropan-2-yl)phenyl)phthalamide, C23H22F7I1N2O4S1
  32. Crystal structure of 1-(2-(4-bromophenyl)-2,3-dihydro-1H-benzo[e]indol-1-yl)-naphthalen-2-ol – dichloromethane – dimethyl sulfoxide (1/1/1), C28H18BrNO·CH2Cl2·C2H6SO
  33. Crystal structure of [meso-5,7,7,12,14,14,-hexamethyl-1,4,8,11-tetraazacyclotetradecane]nickel(II) diperchlorate – dimethylsulphoxide (1/2), C20H48Cl2N4NiO10S2
  34. Crystal structure of 1,1′-(1,3-phenylenebis(methylene))bis(pyridin-1-ium) bis(1,2-dicyanoethene-1,2-dithiolato-κ2 S:S) palladium(II), C26H18N6PdS4
  35. The crystal structure of bis(6-phenylpyridine-2-carboxylato-κ2 N,O)copper(II), C24H16N2O4Cu
  36. Crystal structure of dichlorido-bis(4-chlorophenyl-κC)-bis(triphenylarsine oxide-κO)tin(IV), C48H38As2Cl4O2Sn
  37. Crystal structure of (4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane-κ 8 N 2, O 6) potassium cyclopentadienide, [K([2.2.2]crypt)]Cp, C23H41KN2O6
  38. The crystal structure of bis(2-oxidopyridin-1-ium-3-carboxylato-κ2O,O′)-(phenantroline-κ2N,N′)manganese(II) - methanol (1/3), C27H28N4O9Mn
  39. Crystal structure of 4-(dimethylamino)pyridinium dibromido-tris(4-chlorophenyl-κC)stannate(IV), C25H23Br2Cl3N2Sn
  40. Crystal structure of (3E,5E)-1-(4-cyanobenzenesulfonyl)-3,5-bis(3-fluorobenzylidene)piperidin-4-one-dichloromethane (1/1), C27H20Cl2F2N2O3S
  41. Crystal structure of (3E,5E)-3,5-bis(4-fluorobenzylidene)-1-((4-trifluoromethyl)benzenesulfonyl)piperidin-4-one, C26H18F5NO3S
  42. Crystal structure of chlorido-(4-methyl-2-((phenylimino)methyl)phenolato-κ2 N,O)-(pyridine-κ1 N)platinum(II), C19H17ClN2OPt
  43. Crystal structure of (4-methylbenzyl)(triphenyl)phosphonium chloride dihydrate, C26H28ClO2P
  44. The crystal structure of poly[μ2-chlorido-(μ2-1,2-bis(4-pyridyl)ethane-κ2N:N′silver(I)], C12H12AgClN2
  45. Crystal structure of poly[(μ4-benzene-1,2,4,5-tetracarboxylato)-bis(μ2-adipohydrazide)dicadmium], C11H15N4O6Cd
  46. The crystal structure of (E)-N′-(butan-2-ylidene)isonicotinohydrazide 0.5 hydrate C10H13N3O·0.5H2O
  47. The crystal structure of bis(6-phenylpyridine-2-carboxylate-κ2 N,O)-(2,2′-bipyridine-κ2 N,N′)zinc(II) monohydrate, C34H26N4O5Zn
  48. The crystal structure of (1R *,2S *)-1,2-bis(2-fluorophenyl)-3,8-dimethoxyacenaphthene-1,2-diol, C26H20F2O4
  49. Crystal structure of catena-poly[(μ2-1-((2-ethyl-4-methyl-1H-imidazol-1-yl)methyl)-1H-benzotriazole-κ2N:N′)-(nitrato-κ2O,O′)silver (I)], C13H15Ag1N6O3
  50. The crystal structure of [(phenantroline-κ2 N,N′)-bis(6-phenylpyridine-2-carboxylate-κ2 N,O)cobalt(II)]monohydrate, C36H26N4O5Co
  51. Crystal structure of (1E)-N-[(1E)-1-(4-chlorophenyl)ethylidene]-2-[1-(4-chlorophenyl)ethylidene]hydrazine-1-carbohydrazonamide, C 17 H 17 Cl 2 N 5
  52. The crystal structure of (E)-2-((tert-butylimino)methyl)-4-chlorophenol, C11H14ClNO
  53. Crystal structure of all-cis-2,4,6-trihydroxycyclohexane- 1,3,5-triaminium chloride sulfate, C6H18ClN3O7S
  54. Crystal structure of dichlorido-bis(dimethyl sulfoxide-κO)bis(4-methylphenyl-κC 1)tin(IV), C18H26Cl2O2S2Sn
  55. Crystal structure of dichlorido-bis(4-chlorophenyl-κC 1)(2,2′-bipyridyl-κ 2 N,N′)tin(IV), C22H16Cl4N2Sn
  56. Redetermination of the crystal structure of (E)-5-bromo-2-hydroxybenzaldehyde oxime, C 7 H 6 BrNO 2
  57. The crystal structure of (E)-amino(2-(4-methylbenzylidene)hydrazineyl)methaniminium 4-methylbenzoate, C9H13N4 + C8H7O2
  58. Crystal structure of 2-chloro-3-(isopentylamino)naphthalene-1,4-dione, C 15 H 16 ClNO 2
  59. The crystal structure of bis(2-acetyl-5-methoxyphenyl)carbonate 1.5 hydrate, C19H18O7
  60. The crystal structure of poly[(μ 4-4,4′-(azanediylbis(methylene))dibenzoato-κ 4 O:N:O′:Oʺ)zinc(II)], C16H13NO4Zn
  61. The crystal structure of catena-poly[(1,10-phenanthroline-k2N,N′)-(μ3-tetraoxidomoybdato(VI)-k3O:O′:O″)manganese(II)] C12H8N2O4MoMn
  62. Crystal structure of catena-poly[(4-hydroxyl-5-(methoylcarbonyl)thiophene-2-carboxylato-κ1 O)-(μ2-piperazine-1,4-diylbis(pyridin-4-ylmethanone)-κ2 N:N′)silver(I)] monohydrate, C23H23AgN4O8S
  63. Crystal structure of bis(4-bromo-2-(((3-bromopropyl)imino)methyl)phenolato-κ2N,O)-oxido-vanadium(IV), C20H20Br4N2O3V
  64. The crystal structure of (2a′S,2a1′S,3R,5a′S,7′R)-5-(furan-3-yl)-2a′,2a1′-dihydroxy-7′-methyldecahydro-2H-spiro[furan-3,6′-naphtho[1,8-bc]furan]-2,2′(2a′H)-dione, C19H22O7
  65. The crystal structure of 3-bromopicolinic acid, C6H4BrNO2
  66. Crystal structure of 1,1′-(1,4-phenylenebis(methylene))bis(pyridin-1-ium) bis(1,2-dicyanoethene-1,2-dithiolato-κ2 S,S) platinum(II), C26H18N6PtS4
  67. Synthesis and crystal structure of 5-(8-((3-carboxyazetidin-1-ium-1-yl)methyl)-7-hydroxy-4-oxo-4H-chromen-3-yl)-2-hydroxybenzenesulfonate monohydrate, C20H19NO10S
  68. The crystal structure of 3-amino-5-carboxypyridin-1-ium bromide, C6H7BrN2O2
  69. The crystal structure of (2-hydroxy-5-methyl-phenyl)-(1H-pyrazol-4-yl)-methanone hemihydrate, C11H10.5N2O2.5
  70. Crystal structure of tetraaqua-(2-(4-formylphenoxy)acetato-k1O)cadmium(II), C18H22O12Cd
  71. Crystal structure of diethyl 6,12-dimethyl-3,9-di-p-tolyl-3,9-diazapentacyclo[6.4.0.02,7.04,11.05,10]dodecane-1,5-dicarboxylate, C32H38N2O4
  72. Crystal structure of (E)-N′-(1-(3-chloro-4-fluorophenyl)ethylidene)-4-hydroxy – tetrahydrofuran (2/1), C17H16ClFN2O2.5
Heruntergeladen am 16.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2021-0301/html
Button zum nach oben scrollen